2Todd R,Golub TR,Arceci RT.Acute myelogenous leukemia in:Pizzo PA,Poplack DG.principles and practice of pediatric oncology.5th ed.Philadephia:Lippincott Williams & Wilkins,2006 ;591-644.
3Razzouk BI,Estey E,Pounds S,et al.Impact of age on outcome of pediatric acute myeloid leukemia:a report from 2 institutions.Cancer,2006 Jun 1; 106(11):2495-502.
4Lapillonne H,Renneville A,Auvrignon A,et al.High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.J Clin Oncol.2006 Apr 1;24(10):1507-1515.
5Eric L.Sievers,Beverly J.Lange,Todd A,et al.lmmunophenotypic evidence of leukemia after induction therapy predicts relapse:results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.Blood,2003 May 1;101 (9):3398-3406.
6Coustan-Smith E,Ribeiro RC,Rubnitz JE,et al.Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia.Br J Haematol,2003; 123:243-252.
7Jehe S,Gandhi V,Chan KW,et al.Clofarabine,a novel nucleoside analog,is active in pediatric patients with advanced leukemia.Blood,2004 Feb 1 ;103(3):784-789.
8de Botton S,Coiteux V,Chevret S,et al.Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.J Ciin Oncol,2004 Apr 15;22(8):1404-1412.
9Hicsonmez G.The effect of steroid on myeloid leukemic cells:the potential of short-course high-dose methylprednisolone treatment in inducing differentiation,apoptosis and in stimulating myelopoiesis.Leuk Res,2006 Jan;30(1):60 -68.
10George B,Mathews V,Poonkuzhali B,et al.Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide:a single center experience.Leukemia,2004;18:1587-1590.
5Kern W,Haferlach T,Schnittger S,et al.Prognosis in therapy-related acute myeloid leukemia and impactofkaryotype.JCImOncol,2004;22(12):2510-2511.
6Pulsom A,Pagano L.Treatment of secondary acute myeloid leukemia.J Clin Oncol,2005;23(4):926-927.
7胡亚美,江载芳,陆华,等.实用儿科学.第7版.北京:2008 2210-2211.
8Lu GH.Clinical cytogenetic diagnosis of therapy-related acute myeloid leukemia.北京大学学报(医学版),2005;37(1):10-13.
9Le Deley MC,Leblanc T,Shamsaldin A,et al.Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclmes:A case-control study by the Societe Francaise d'Oncologie Pediatrique.J Clm Oncol,2003;21(6):1074-1081.
10Bamard DR,Woods WG.Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer-an update.Leuk Lymphom,2005;46(5):651-662.
